A call to arms: a critical need for interventions to limit pulmonary toxicity in the stem cell transplantation patient population. [electronic resource]
- Current hematologic malignancy reports Mar 2015
- 8-17 p. digital
Publication Type: Journal Article
1558-822X
10.1007/s11899-014-0244-z doi
Anti-Bacterial Agents--therapeutic use Bronchiolitis Obliterans--etiology Hematopoietic Stem Cell Transplantation--adverse effects Humans Immunologic Factors--therapeutic use Immunosuppressive Agents--administration & dosage Lung Transplantation Pneumonia--etiology Protein Kinase Inhibitors--therapeutic use Quality of Life